元迈生物于2022年9月成立，定位于专注巨噬细胞免疫治疗药物研发的平台型公司。元迈细胞瞄准胃癌、肝癌、前列腺癌等临床需求尚未被满足的实体瘤及自身免疫性疾病治疗领域，立足于研发创新 CAR巨噬细胞（CAR-Macrophage，简称CAR-M）技术 。

血液瘤起源于人体血液、骨髓、淋巴系统，分为白血病、淋巴瘤、骨髓瘤三大类。中国每年新发血液瘤患者总数约16万—20万，数量不及实体瘤，但在35岁以下人群中标化死亡率排名第一，其中淋巴瘤最为严重，发病率和死亡率均居全部恶性肿瘤前十位。

With the Car and Driver Ten Best decided, the North American Car and Truck of the Year finalists announced and Cadillac, Ram and Subaru chalking up wins with Motor Trend, it’s fair to say that the ...

When it comes to automotive innovation, some engines stand out not just for their power or efficiency, but for how they reshaped the industry and our expectations of what cars can achieve. Today, ...

Growing up, Motor Trend was basically Chris' bible. With an ever growing TikTok fan base, Chris decided it was time to take the more serious journalistic approach to talking about his favorite subject ...

K-Car轻型汽车（又称“轻自动车”，Kei jidōsha）在日本是一种相当普遍的车型，当地可说是遍地K-Car。国内电动车巨头比亚迪特别针对日本市场推出全新轻型电动车Racco，打算在K-Car领域抢占一席之地。